
Venus Remedies Q1 FY27: consolidated PAT jumps ~139% YoY to ₹22.97 Cr, margins expand
Pharma & Biotech · earnings · quarterly results

Pharma & Biotech · earnings · quarterly results

Auto & EV · earnings · quarterly results

earnings · quarterly results · q4 results

earnings · quarterly results · q4 results

ad growth · newsprint inflation · margin resilience

Industrials · earnings · quarterly results

MASH · GLP-1 RA · semaglutide

Real Estate · earnings · quarterly results

PAT growth · NIM expansion · Asset Finance challenge


US market entry · Export growth · Mid-cap cables


Motor TP headwind · margin compression · retail health growth



commodity chemicals · EDC production · factory fire

VAP expansion · procurement inflation · margin compression

steel · long products · margin expansion


Q1 FY27 results · turnaround · supply chain

asset quality recovery · co-lending exit · rate upgrade benefit


GPCB · environmental compliance · amines






volume deceleration · pricing power · FMEG momentum

Banking · Credit growth · NPA compression